Abstract
This article briefly discusses nonalcoholic fatty liver disease (NAFLD) and its association with the metabolic syndrome, its pathogenesis and natural history. It then presents a detailed discussion on the efficacy and safety of different insulin sensitizers in patients who have NASH.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1067-1087 |
| Number of pages | 21 |
| Journal | Endocrinology and Metabolism Clinics of North America |
| Volume | 36 |
| Issue number | 4 |
| DOIs | |
| State | Published - Dec 2007 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Endocrinology
- Biochemistry
Cite this
Use of Insulin Sensitizers in NASH. / Khashab, Mouen; Chalasani, Naga.
In: Endocrinology and Metabolism Clinics of North America, Vol. 36, No. 4, 12.2007, p. 1067-1087.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Use of Insulin Sensitizers in NASH
AU - Khashab, Mouen
AU - Chalasani, Naga
PY - 2007/12
Y1 - 2007/12
N2 - This article briefly discusses nonalcoholic fatty liver disease (NAFLD) and its association with the metabolic syndrome, its pathogenesis and natural history. It then presents a detailed discussion on the efficacy and safety of different insulin sensitizers in patients who have NASH.
AB - This article briefly discusses nonalcoholic fatty liver disease (NAFLD) and its association with the metabolic syndrome, its pathogenesis and natural history. It then presents a detailed discussion on the efficacy and safety of different insulin sensitizers in patients who have NASH.
UR - http://www.scopus.com/inward/record.url?scp=35648951688&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=35648951688&partnerID=8YFLogxK
U2 - 10.1016/j.ecl.2007.07.006
DO - 10.1016/j.ecl.2007.07.006
M3 - Article
C2 - 17983937
AN - SCOPUS:35648951688
VL - 36
SP - 1067
EP - 1087
JO - Endocrinology and Metabolism Clinics of North America
JF - Endocrinology and Metabolism Clinics of North America
SN - 0889-8529
IS - 4
ER -